WebK UALA LUMPUR (March 22): The Drug Control Authority under the Ministry of Health Malaysia has issued a cancellation and product recall of Pholcodine, an opioid medicine that is used in adults... WebApr 10, 2024 · Many general practitioners (GPs) have been prescribing pholcodine-based medications for many years without any problems, said Dr Raj Kumar Maharajah, president of Medical Practitioners Coalition Association of Malaysia. He added that GPs were required to keep records when pholcodine was prescribed.
Pholcodine C23H30N2O4 - PubChem
WebApr 12, 2024 · The South African Health Products Regulatory Authority (Sahpra) has withdrawn all pholcodine-containing medicines from the market due to the increased risk of sudden, severe and life-threatening allergic reactions occurring during surgery, reports MedicalBrief. This follows a local probe launched last month after a global withdrawal, … WebPholcodine is an opioid medicine that is used for the treatment of non-productive (dry) cough in children and adults. It works directly in the brain, depressing the cough reflex by reducing the nerve signals that are sent to the muscles involved in coughing. Pholcodine has been used as a cough suppressant since the 1950s. nourish me home
Pholcodine cough medicines withdrawn in UK over allergy fears
WebMar 1, 2024 · What is pholcodine? Pholcodine (pronounced pho-co-dean) is an opioid-based medicine, which means it’s related to morphine and codeine. It works by binding to various opioid receptors in a part ... In Malaysia, pholcodine is classified as a Class C controlled drug, meaning it can be sold without a prescription. A list of medications registered with Malaysia’s Drug Control Authority containing either pholcodine only or pholcodine in combination with other drugs. WebMar 31, 2024 · Recall of cough meds with pholcodine no cause for alarm: health orgs. Malaysia / 3d. No Marburg virus case in Malaysia for now: health minister. Malaysia / 4d. TB death rate up 12% in 2024: health minister. Malaysia / 5d. Better safe than sorry, we can’t deny PrEP to high-risk groups: MoH. nourish md